ChemOutsourcing 2025, the premier US-based pharmaceutical sourcing event, returns September 2 to 5 in Parsippany, NJ. The show will feature over 100 global CDMOs from more than 30 countries, making it a key global hub for pharmaceutical development and manufacturing partnerships.
The event connects biotech and pharma innovators with development and manufacturing partners specializing in custom small molecule APIs, generics, peptides, oligonucleotides, and complex formulations. Attendees will engage with companies offering services across the full drug lifecycle, from early-stage development to commercial supply.
This year’s program features panels on peptide and oligonucleotide manufacturing, GLP-1 drug development, high-potency APIs, and global supply chain strategy. Discussions are led by CEOs, C-suite executives, sourcing leaders, regulatory experts, and investment analysts from top pharmaceutical and biotech organizations, offering forward-looking insights into outsourcing trends and industry dynamics.
A personalized meeting portal allows buyers and exhibitors to schedule one-on-one meetings in advance, with access to private meeting rooms on site to support business development and partnership opportunities.
ChemOutsourcing draws a uniquely focused audience of pharmaceutical executives, biotech founders, sourcing professionals, and business development leaders. The event offers a powerful platform to build visibility, form global partnerships, and stay ahead of evolving market dynamics.
2
